Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer.

Takahide ToyodaToshiko KamataKazuhisa TanakaFumie IharaMariko TakamiHidemi SuzukiTakahiro NakajimaTakayuki IkeuchiYohei KawasakiHideki HanaokaToshinori NakayamaIchiro YoshinoShinichiro Motohashi

Published in: Journal for immunotherapy of cancer (2021)

UMIN000007321.

Keyphrases

phase ii study
induced apoptosis
open label
locally advanced
cell cycle arrest
case report
endoplasmic reticulum stress
oxidative stress
signaling pathway
cell death
rectal cancer
placebo controlled
pi k akt